Healthy Volunteer
Conditions
Interventions
4-weeks intake of SNR14-containing food
4-weeks intake of the placebo food
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Subjects who have obtained written consent for participation in the research. 2)Healthy men and women between 20 and 79. 3)Subject who can take meals, eat test foods, etc., take blood samples, take urine samples, and stay quiet and rest on the schedule indicated by investigators.
Exclusion criteria
Exclusion criteria: 1)Subjects whose clinical inspection results are outside of the normal range and who are est imated inappropriate to this study. 2)Subjects who had a serious major organ / internal organ or who are currently undergoing treatment and who are estimated inappropriate to this study. 3)As a general rule, those who regularly use drugs for the purpose of treating diseases. 4)Subjects who have allergy. 5)Lactating people, pregnant women or those who may be pregnant, and those who wish to become pregnant during the study period. 6)Subjects who are estimated inappropriate to this study by principal investigator or investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (Safety evaluation) Blood test items,urinalysis items,general physical findings (subjective symptoms,objective findings),vital signs(blood pressure,pulse rate),physical measurements(body weight,body fat percentage,lean body mass),frequency of adverse events (Measurement item) Urinary excretion of SNR14,Plasma concentration of SNR14 | — |
Countries
Japan
Contacts
Public ContactDaisuke Ochitani
HUMA R&D CORP Clinical Development Division
Outcome results
None listed